Auxagen
Business Services · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4041 Forest Park Ave, St. Louis, Missour...Phone Number
(314) 593-5674Website
www.auxagen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Auxagen
Auxagen, Inc. was founded in 2004 to develop TGF- receptor antagonists to treat wounds and tissue fibrosis which currently lack effective therapy. Many lines of evidence indicate that TGF- is an ideal target for developing novel therapeutic agents to treat wounds and tissue fibrosis. We have developed novel TGF- receptor antagonist products which exhibit potent TGF- antagonist activity and growth promoting effects on epithelial and endothelial cells. These products are effective in enhancing wound healing and reducing scarring by topical administration and in ameliorating and reversing lung fibrosis by intranasal administration in relevant animal models. These products are currently in preclinical trials. An ongoing SBIR phase II study on wound treatment is expected to result in an IND filing in 2013. A SBIR phase I study on lung fibrosis treatment has been completed.Explore more
Auxagen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Auxagen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Auxagen
Earning: See what the market has to say on Auxagen recently announced quarterly report
Check if Auxagen has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Auxagen launches new products
Funding: Get notified immidiatlly once Auxagen has new funding data
Check out if Auxagen is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Auxagen had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Auxagen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Auxagen as Masked Content
Find 2 more new buyers
Compare Similar Companies to Auxagen
Compare insights from companies similar to Auxagen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Auxagen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Auxagen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Auxagen.
Auxagen Tech Stack
A closer look at the technologies used by Auxagen
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Auxagen
Sign Up For FreeTo access detailed company insights
Auxagen, Inc. was founded in 2004 to develop TGF- receptor antagonists to treat wounds and tissue fibrosis which currently lack effective therapy. Many lines of evidence indicate that TGF- is an ideal target for developing novel therapeutic agents to treat wounds and tissue fibrosis. We have developed novel TGF- receptor antagonist products which e... Read More
